ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 6, June 2025 | pp. 265–275
DOI: 10.46882/AJIDR/148805
Article Type: Research Article
Title: Prevalence and risk factors of Mycoplasma genitalium and macrolide resistance mutations among patients with non-gonococcal urethritis
Names of Authors: Sipho Ndlovu¹*, Claire Dubois²
Authors’ Affiliations: ¹Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa. ²Department of Genitourinary Medicine, Sorbonne University, Paris, France.
Abstract: Mycoplasma genitalium is an emerging sexually transmitted pathogen increasingly resistant to first-line macrolide and fluoroquinolone regimens. We investigated the prevalence of Mycoplasma genitalium and 23S rRNA macrolide resistance mutations among men presenting with non-gonococcal urethritis. First-void urine samples from 270 symptomatic patients were analyzed using multiplex real-time polymerase chain reaction and Sanger sequencing. Mycoplasma genitalium was detected in 16.3 percent of patients, with A2058G and A2059G macrolide resistance mutations identified in 38.6 percent of positive cases. Prior azithromycin treatment for syndromic urethritis strongly predicted resistance. Resistance-guided sequential therapy using doxycycline followed by moxifloxacin is recommended.
Keywords: Mycoplasma genitalium, Non-gonococcal urethritis, Macrolide resistance, Sexually transmitted infections, Molecular diagnostics
Citation: Ndlovu S, Dubois C (2025). Prevalence and risk factors of Mycoplasma genitalium and macrolide resistance mutations among patients with non-gonococcal urethritis. African Journal of Infectious Diseases Research, 12(6): 265–275. DOI: 10.46882/AJIDR/148805
Manuscript Timeline: Received: April 23, 2025; Revised: May 26, 2025; Accepted: June 10, 2025; Published: June 18, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read